Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

NASDAQ:ECOR - Nasdaq - US28531P2020 - Common Stock - Currency: USD

5.339  -1.47 (-21.6%)

Fundamental Rating

3

Taking everything into account, ECOR scores 3 out of 10 in our fundamental rating. ECOR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While ECOR seems to be doing ok healthwise, there are quite some concerns on its profitability. ECOR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ECOR has reported negative net income.
ECOR had a negative operating cash flow in the past year.
In the past 5 years ECOR always reported negative net income.
In the past 5 years ECOR always reported negative operating cash flow.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ECOR has a worse Return On Assets (-58.06%) than 70.37% of its industry peers.
Looking at the Return On Equity, with a value of -157.56%, ECOR is doing worse than 68.25% of the companies in the same industry.
Industry RankSector Rank
ROA -58.06%
ROE -157.56%
ROIC N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With an excellent Gross Margin value of 84.97%, ECOR belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
In the last couple of years the Gross Margin of ECOR has grown nicely.
ECOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECOR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ECOR has more shares outstanding
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ECOR has an Altman-Z score of -10.15. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
ECOR's Altman-Z score of -10.15 is on the low side compared to the rest of the industry. ECOR is outperformed by 78.31% of its industry peers.
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.15
ROIC/WACCN/A
WACC8.94%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 1.78 indicates that ECOR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, ECOR is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
ECOR has a Quick Ratio of 1.60. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
ECOR's Quick ratio of 1.60 is in line compared to the rest of the industry. ECOR outperforms 40.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.6
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

ECOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.07%, which is quite impressive.
Looking at the last year, ECOR shows a very strong growth in Revenue. The Revenue has grown by 57.09%.
The Revenue has been growing by 60.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.62%
Revenue 1Y (TTM)57.09%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%23.46%

3.2 Future

Based on estimates for the next years, ECOR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.66% on average per year.
Based on estimates for the next years, ECOR will show a very strong growth in Revenue. The Revenue will grow by 21.84% on average per year.
EPS Next Y20.36%
EPS Next 2Y43.43%
EPS Next 3Y41.66%
EPS Next 5YN/A
Revenue Next Year29.95%
Revenue Next 2Y37.87%
Revenue Next 3Y37.45%
Revenue Next 5Y21.84%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.
ECOR is valuated quite expensively with a Price/Forward Earnings ratio of 57.95.
Based on the Price/Forward Earnings ratio, ECOR is valued a bit cheaper than the industry average as 66.14% of the companies are valued more expensively.
ECOR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.35.
Industry RankSector Rank
PE N/A
Fwd PE 57.95
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ECOR's earnings are expected to grow with 41.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.43%
EPS Next 3Y41.66%

More info and screens

0

5. Dividend

5.1 Amount

ECOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROCORE INC

NASDAQ:ECOR (5/8/2025, 9:52:56 AM)

5.339

-1.47 (-21.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners18.95%
Inst Owner Change-0.26%
Ins Owners18.26%
Ins Owner Change0.65%
Market Cap38.39M
Analysts83.64
Price Target25.7 (381.36%)
Short Float %5.14%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.23%
Min EPS beat(2)-27.74%
Max EPS beat(2)9.28%
EPS beat(4)3
Avg EPS beat(4)3.55%
Min EPS beat(4)-27.74%
Max EPS beat(4)17.87%
EPS beat(8)5
Avg EPS beat(8)-0.84%
EPS beat(12)5
Avg EPS beat(12)-4.22%
EPS beat(16)8
Avg EPS beat(16)1.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-2.02%
Max Revenue beat(2)-1.04%
Revenue beat(4)2
Avg Revenue beat(4)4.31%
Min Revenue beat(4)-2.02%
Max Revenue beat(4)11.95%
Revenue beat(8)4
Avg Revenue beat(8)3.45%
Revenue beat(12)7
Avg Revenue beat(12)2.42%
Revenue beat(16)8
Avg Revenue beat(16)1.38%
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-97.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-137.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 57.95
P/S 1.52
P/FCF N/A
P/OCF N/A
P/B 5.09
P/tB 5.09
EV/EBITDA N/A
EPS(TTM)-1.56
EYN/A
EPS(NY)0.09
Fwd EY1.73%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS3.5
BVpS1.05
TBVpS1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.06%
ROE -157.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.97%
FCFM N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.6
Altman-Z -10.15
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.62%
EPS Next Y20.36%
EPS Next 2Y43.43%
EPS Next 3Y41.66%
EPS Next 5YN/A
Revenue 1Y (TTM)57.09%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%23.46%
Revenue Next Year29.95%
Revenue Next 2Y37.87%
Revenue Next 3Y37.45%
Revenue Next 5Y21.84%
EBIT growth 1Y36.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.63%
OCF growth 3YN/A
OCF growth 5YN/A